Li Zhang
Sichuan University
432 Papers
815 Citations
Li Zhang is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 37, co-authored 298 publications. Previous affiliations of Li Zhang include Tianjin Medical University Cancer Institute and Hospital & Queen's University Belfast.
Chat about Author
Papers
Interface Engineering in Ferroelectrics: from Films to Bulks
TL;DR: In this article , the authors focused more on the utilizing of interfaces in different states of ferroelectrics such as: Tuning magnetoelectric coupling coefficient by terminated layer in epitaxial thin films; broadening Curie temperature range by inducing interfacial stain; enhancing dielectric tunability by forming topological structures; increasing electrical breakdown strength introducing artificial interfaces, etc.
The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study.
Feiwu Long,Chenghan Xiao,Huijie Cui,Wei Wang,Zongze Jiang,Mingshuang Tang,Wen-Qian Zhang,Yunjie Liu,Rong Xiang,Li Zhang,Xunying Zhao,Chao Yang,Pei-jing Yan,Xueyao Wu,Yutong Wang,Yanqiu Zhou,Ran Lu,Yu-Long Chen,Jiayuan Li,Xia Jiang,Chuanwen Fan,Ben Zhang +21 more
TL;DR: There is evidence that genetically elevated IgG N-glycosylation traits may have a causal effect on diverse COVID-19 outcomes, and these findings have potential implications for developing targeted interventions to improve COIDs outcomes by modulating IgGN-glyCosylation levels.
Heterogeneity in lung cancers by single‐cell DNA sequencing
Li Zhang,Lingxi Chen,Shuai Cheng Li,Mengyao Wang,Chaohui Li,Tingting Song,Yinyun Ni,Ying Yang,Zhiqiang Liu,Menglin Yao,Bairong Shen,Weimin Li +11 more
TL;DR: Heterogeneity in lung cancers by single-cell DNA sequencing reveals molecular subgroups and potential therapeutic targets.
Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery
Yao Qin,Huali Chen,Wenmin Yuan,Rui Kuai,Qianyu Zhang,Fulan Xie,Li Zhang,Zhirong Zhang,Ji Liu,Qin He +9 more
TL;DR: Experimental data indicated that the TAT-LIP was a promising brain drug delivery system due to its high delivery efficiency across the blood-brain barrier (BBB).
A tumor-activatable particle with antimetastatic potential in breast cancer via inhibiting the autophagy-dependent disassembly of focal adhesion.
TL;DR: It is proved that D/PSP@CQ/CaP decreased the cancer metastatic extent by 7.5 folds (vs. Control) on mice model via inhibiting the autophagy-dependent disassembly of focal adhesion, and the growth rate of tumors treated by D/ PSP was inhibited by 9.1 folds, which could be attributed to its effective tumor drug delivery.